(Q37738573)

22 August 2017

1 reference

title

MicroRNA expression in acute myeloid leukemia (English)

1 reference

22 August 2017

0 references

1 reference

1

Guido Marcucci

1 reference

22 August 2017

4

Clara D Bloomfield

1 reference

22 August 2017

3

Krzysztof Mrózek

1 reference

22 August 2017

Michael D Radmacher

2

1 reference

22 August 2017

1 April 2009

1 reference

Current hematologic malignancy reports

22 August 2017

1 reference

22 August 2017

4

1 reference

22 August 2017

83-88

1 reference

22 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11899-009-0012-7

22 August 2017

0 references

cites work

Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin

1 reference

12 December 2020

Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study

1 reference

12 December 2020

MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia

1 reference

12 December 2020

Molecular characterization of acute myeloid leukemia

1 reference

12 December 2020

Acute myeloid leukaemia

1 reference

12 December 2020

Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study

1 reference

12 December 2020

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

1 reference

12 December 2020

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

1 reference

12 December 2020

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

1 reference

12 December 2020

MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis

1 reference

12 December 2020

Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia

1 reference

12 December 2020

Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia

1 reference

12 December 2020

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

1 reference

12 December 2020

Treatment of acute myeloid leukemia

1 reference

12 December 2020

MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia

1 reference

12 December 2020

MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis.

1 reference

12 December 2020

High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics

1 reference

12 December 2020

Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation

1 reference

12 December 2020

MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia

1 reference

12 December 2020

Widespread microRNA repression by Myc contributes to tumorigenesis

1 reference

12 December 2020

The functions of animal microRNAs

1 reference

12 December 2020

Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia

1 reference

12 December 2020

Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study

1 reference

12 December 2020

Chromosomal abnormalities in cancer

1 reference

12 December 2020

An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia

1 reference

12 December 2020

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

1 reference

12 December 2020

MicroRNA biogenesis and cancer

1 reference

12 December 2020

Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study

1 reference

12 December 2020

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

12 December 2020

MicroRNAs: new regulators of immune cell development and function

1 reference

12 December 2020

A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects

1 reference

12 December 2020

High Expression Levels of theETS-Related Gene,ERG, Predict Adverse Outcome and Improve Molecular Risk-Based Classification of Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

1 reference

12 December 2020

MicroRNA signatures in human cancers

1 reference

12 December 2020

Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia

1 reference

12 December 2020

MicroRNA expression in cytogenetically normal acute myeloid leukemia

1 reference

12 December 2020

Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder

1 reference

12 December 2020

Discovery, biology and therapeutic potential of RNA interference, microRNA and antagomirs

1 reference

12 December 2020

Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party

1 reference

12 December 2020

Prognostically useful gene-expression profiles in acute myeloid leukemia.

1 reference

12 December 2020

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

1 reference

12 December 2020

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

1 reference

12 December 2020

Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling

1 reference

12 December 2020

Identification of acute myeloid leukaemia associated microRNA expression patterns

1 reference

12 December 2020

Distinct microRNA expression profiles in acute myeloid leukemia with common translocations.

1 reference

12 December 2020

Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia

1 reference

12 December 2020

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

1 reference

12 December 2020

MicroRNAs in normal and malignant hematopoiesis

1 reference

12 December 2020

High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CAL

1 reference

12 December 2020

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

12 December 2020

10.1007/S11899-009-0012-7

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20425419